Edition:
United Kingdom

Aptinyx Inc (APTX.OQ)

APTX.OQ on NASDAQ Stock Exchange Global Select Market

3.22USD
16 Aug 2019
Change (% chg)

-- (--)
Prev Close
$3.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
67,968
52-wk High
$32.25
52-wk Low
$2.88

About

Aptinyx Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapies for disorders of the brain and nervous system. The Company has a platform for discovering compounds that work through a mechanism, which includes modulation of the N-methyl-D-aspartate (NMDA) receptor to develop pathways... (more)

Overall

Beta: --
Market Cap(Mil.): $125.19
Shares Outstanding(Mil.): 33.56
Dividend: --
Yield (%): --

Financials

  APTX.OQ Industry Sector
P/E (TTM): -- 29.73 33.85
EPS (TTM): -1.76 -- --
ROI: -53.79 13.04 12.69
ROE: -139.16 14.12 17.13

Allergan depression treatment fails studies, shares slip

Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

06 Mar 2019

UPDATE 2-Allergan depression treatment fails studies, shares slip

March 6 Allergan Plc said on Wednesday its experimental add-on treatment for depression failed three late-stage studies, casting doubts over its drugs pipeline and sending the Botox-maker's shares down nearly 4 percent after the bell.

06 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates